Shopping Cart
- Remove All
- Your shopping cart is currently empty
NT376 is a potent and selective inhibitor of class IIa Histone deacetylases (HDAC), exhibiting an IC50 value of 32 nM and demonstrating efficacy similar to NT160 (IC50 = 46 nM) in HT-29 cells. This compound is a promising candidate for research into various cancers and central nervous system (CNS) disorders, including Alzheimers and Huntingtons diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | NT376 is a potent and selective inhibitor of class IIa Histone deacetylases (HDAC), exhibiting an IC50 value of 32 nM and demonstrating efficacy similar to NT160 (IC50 = 46 nM) in HT-29 cells. This compound is a promising candidate for research into various cancers and central nervous system (CNS) disorders, including Alzheimers and Huntingtons diseases. |
Targets&IC50 | HDAC5:2.85 nM (HT-29 cells), Class I/IIb:>4000 nM (HT-29 cells), HDAC11:4851 nM (HT-29 cells), HDAC6:5035 nM (HT-29 cells), HDAC4:1.26 nM (HT-29 cells), HDAC1:1483 nM (HT-29 cells) |
In vitro | NT376 exhibits high selectivity and potency for Class IIa Histone deacetylases (HDAC) (IC50 = 32 nM) in HT-29 cells, with concentrations ranging from 1.26-5035 nM over 3 hours. It demonstrates superior effectiveness over other HDAC categories (IC50 = >4.0 µM) and slightly outperforms NT160 in functional cellular assays. |
Molecular Weight | 436.4 |
Formula | C21H20F4N4O2 |
Cas No. | 2820208-97-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.